Earnings Preview: West Pharmaceutical Services (WST) Q1 Earnings Expected to Decline
West Pharmaceutical (WST) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its…
214,415$
1,82%
Echtzeit-Aktienkurs West Pharmaceutical Services Inc.
Bid:
Ask:
Nachrichten zur West Pharmaceutical Services Inc. Aktie
West Pharmaceutical Services Aktie: Mehr als vorgesehen?
Analyse der aktuellen Börsenperformance von West Pharmaceutical Services mit strategischer Neuausrichtung nach Beendigung wichtiger Kundenpartnerschaften. Die Aktie von West Pharmaceutical…
West Pharmaceutical Services (WST) Surpasses Q4 Earnings and Revenue Estimates
West Pharmaceutical (WST) delivered earnings and revenue surprises of 4% and 1.25%, respectively, for the quarter ended December 2024. Do…
Will Segmental Performance Drive West Pharmaceuticals Q4 Earnings?
West Pharmaceutical Services eyes fourth-quarter growth amid pharma stabilization, biologics rebound & contract manufacturing gains. Can WST sustain its momentum?…
West Pharmaceutical Services started at buy by Citi
…
West Pharmaceutical Services announces share repurchase program
…
Whats in Store for West Pharmaceutical in Q3 Earnings?
WSTs third-quarter 2024 results are likely to reflect weakness in its Proprietary Products business. Unfavorable currency movements might have hurt…
West Pharmaceutical Services Aktie: Kursanstieg trotz Monatsrückgang
Der Aktienkurs von West Pharmaceutical Services zeigt eine gemischte Performance. Am 19. Oktober 2024 verzeichnete die Aktie einen Anstieg von…
West Pharmaceutical Services Aktie: Quartalsbericht steht bevor
Die West Pharmaceutical Services Aktie zeigt sich kurz vor der Veröffentlichung des nächsten Quartalsberichts am 24. Oktober 2024 relativ stabil.…
West Pharmaceutical Services Aktie: Stabiler Kurs trotz Marktschwankungen
Die West Pharmaceutical Services Aktie zeigt sich in einem volatilen Marktumfeld relativ stabil. Zum Handelsschluss am 22. September 2024 notierte…
Whats in Store for West Pharmaceutical (WST) in Q2 Earnings?
West Pharmaceuticals (WST) second-quarter 2024 results are likely to reflect strength in its Proprietary Products business. However, unfavorable currency movements…
Global Closed System Transfer Devices Market Size To Worth USD 3.35 Billion By 2033 l CAGR of 9.93%
The Global Closed System Transfer Devices Market Size was Valued at USD 1.3 Billion in 2023 and the Worldwide Closed…
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.…
West Pharmaceutical: Pick And Shovels Of The Injectable Drug Industry
…
West Pharmaceutical Services, Inc. 2024 Q1 - Results - Earnings Call Presentation
…
West Pharmaceutical Services, Inc. (WST) Q1 2024 Earnings Call Transcript
…
West Pharmaceutical (WST) Q1 Earnings Beat, HVP Sales Weak
West Pharmaceuticals (WST) first-quarter results reflect a strong demand for non-COVID-19 products, especially HVP devices.…
Is a Beat Likely for West Pharmaceutical (WST) in Q1 Earnings?
West Pharmaceuticals (WST) first-quarter 2024 results are likely to reflect strength in its Proprietary Products business. However, unfavorable currency movements…
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.…
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.…
Kurs von West Pharmaceutical Services steigt etwas (341,5054 €)
An der US-amerikanischen Börse liegt die West Pharmaceutical Services-Aktie aktuell im Plus. Zuletzt zahlten Investoren für das Wertpapier 372,90 US-Dollar.…
West Pharmaceutical Services-Aktie: Kurs fällt ab (311,4030 €)
Im Minus liegt zur Stunde die Aktie von West Pharmaceutical Services . Zuletzt zahlten Investoren für die Aktie 339,94 US-Dollar.…